228 views
0

WHY THIS MATTERS IN BRIEF

Today millions of people in the world, for a variety of reasons, have trouble moving their bodies, but new brain controlled exoskeletons could help them regain their movement and rehabilitate them at the same time.

 

People familiar with the Terminator series from the 1980’s and 1990’s will remember a little well-known company called Cyberdyne who stumbled upon some Terminator parts “from the future” and used them to create, well, a whole array of advanced robotics products in the present day. Now, a company of the same name in Japan, has just announced that it’s become the first robotics company to receive FDA approval for a new autonomous, brain controlled robotic human exoskeleton.

 

RELATED
New nanomaterial exploits radiation to create more powerful nuclear reactors

 

In today’s world the Cyberdyne Group is the company behind the “Cyberdyne HAL” which the company is calling “the world’s first robotic medical device,” and HAL, which is short for Hybrid Assistive Limb, is an exoskeleton that “enhances its users’ strength and stability.”

 

Watch HAL In Action

 

HAL’s basically, for want of a better description, a brain controlled exoskeleton for a person’s lower torso that uses a network of “stick on” sensors that are attached to a patients legs that can detect the faint bio-electric signals sent from the patient’s brain to the muscles in their legs, which then triggers the HAL exoskeleton to move in the desired way.

 

RELATED
Quantum sensor breakthrough could one day replace global GPS systems

 

HAL, which can be controlled both autonomously and manually, will now start taking its place in hospitals around the US to help rehabilitate patients who are unable to walk, and while it’s previously been marketed as a medical device within both Europe and Japan the FDA’s medical clearance in the US is now seen by many as validating the exoskeleton’s therapeutic effects, and as a consequence we can expect many more brain controlled Terminator inspired “robo” exoskeletons to follow its lead.

About author

Matthew Griffin

Matthew Griffin, award winning Futurist and Founder of the 311 Institute, a global futures think tank, is described as "The Adviser behind the Advisers." Regularly featured on AP, CNBC, Discovery and RT, his ability to identify and track hundreds of game changing emerging technologies, and explain their impact on global culture, industry and society, is unparalleled. Recognised for the past five years running as one of the world's foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments investors, multi-nationals and regulators around the world envision, build and lead an inclusive future. A rare talent Matthew sits on the Technology and Innovation Committee (TIAC) for Centrica, one of Europe’s largest energy companies, and his recent work includes mentoring XPRIZE teams, building the first generation of biocomputers, helping the world’s largest manufacturers companies envision the next five generations of smartphones and devices, and what comes next, and helping companies including Qualcomm envision the next twenty years of semiconductors. Matthew's clients are the who’s who of industry and include Accenture, Bain & Co, BOA, Blackrock, Bloomberg, Booz Allen Hamilton, BCG, Bentley, Dell EMC, Dentons, Deloitte, Deutsche Bank, Du Pont, E&Y, Fidelity, Goldman Sachs, HPE, Huawei, JPMorgan Chase, KPMG, Lloyds Banking Group, McKinsey, Monsanto, PWC, Qualcomm, Rolls Royce, SAP, Samsung, Schroeder's, Sequoia Capital, Sopra Steria, UBS, the UK's HM Treasury, the USAF and many others.

Your email address will not be published. Required fields are marked *